Arthur P. Staddon
- Oral Surgery top 1%
- Oral and Maxillofacial Pathology 7
- Rheumatology top 0.5%
- Bone Tumor Diagnosis and Treatments 14
- Pulmonary and Respiratory Medicine top 0.5%
- Sarcoma Diagnosis and Treatment 43
- Lung Cancer Treatments and Mutations 7
- Oncology top 2%
- Vascular Tumors and Angiosarcomas 10
- Cancer Diagnosis and Treatment 8
- Gastroenterology top 5%
-
- Cardiac tumors and thrombi 9
-
- Lymphoma Diagnosis and Treatment 8
- Co-authors
- Sant P. ChawlaJean‐Yves BlayScott M. SchuetzeKeith M. SkubitzRobert M. HenshawDavid M. ThomasGeorge D. DemetriKristen N. Ganjoo
- Journals
- Journal of Clinical Oncology (29 papers)Cancer (6 papers)European Journal of Cancer (3 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Arthur P. Staddon
64 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Oral Surgery 621
- Rheumatology 1.1k
- Pulmonary and Respiratory Medicine 2.4k
- Oncology 1.4k
- Gastroenterology 167
Countries citing papers authored by Arthur P. Staddon
This map shows the geographic impact of Arthur P. Staddon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur P. Staddon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur P. Staddon more than expected).
Fields of papers citing papers by Arthur P. Staddon
This network shows the impact of papers produced by Arthur P. Staddon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur P. Staddon. The network helps show where Arthur P. Staddon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Arthur P. Staddon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 30 | |
| 2 | 2018 | 3 | |
| 3 | 2017 | 46 | |
| 4 | Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trialbreakdown → | 2015 | 576 |
| 5 | 2015 | 79 | |
| 6 | 2015 | 58 | |
| 7 | 2014 | 90 | |
| 8 | 2014 | 5 | |
| 9 | 2013 | 21 | |
| 10 | Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 studybreakdown → | 2013 | 430 |
| 11 | 2012 | 56 | |
| 12 | 2011 | 7 | |
| 13 | 2011 | 48 | |
| 14 | 2011 | 70 | |
| 15 | 2010 | 37 | |
| 16 | 2010 | 48 | |
| 17 | 2010 | 37 | |
| 18 | 2010 | 27 | |
| 19 | 2008 | 5 | |
| 20 | 1995 | 25 |
About Arthur P. Staddon
Arthur P. Staddon is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Oncology, having authored 67 papers that have together received 3.5k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (43 papers), Bone Tumor Diagnosis and Treatments (14 papers), Vascular Tumors and Angiosarcomas (10 papers), Cardiac tumors and thrombi (9 papers), Cancer Diagnosis and Treatment (8 papers), Lymphoma Diagnosis and Treatment (8 papers), Oral and Maxillofacial Pathology (7 papers) and Lung Cancer Treatments and Mutations (7 papers). The work is most often cited by research in Oral Surgery (621 citations), Rheumatology (1.1k citations) and Pulmonary and Respiratory Medicine (2.4k citations). Arthur P. Staddon has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Sant P. Chawla, Jean‐Yves Blay, Scott M. Schuetze, Keith M. Skubitz, Robert M. Henshaw, David M. Thomas, George D. Demetri, Kristen N. Ganjoo, Mohammed Milhem and Shreyaskumar Patel. Their work appears in journals such as Journal of Clinical Oncology, Cancer, European Journal of Cancer, The Lancet Oncology and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.